Prostatis Group’s iShares US Broker-Dealers & Securities Exchanges ETF IAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.65M Buy
43,658
+10,732
+33% +$1.91M 1.78% 12
2026
Q1
$5.41M Sell
32,926
-26,687
-45% -$4.67M 1.38% 13
2025
Q4
$10.7M Buy
59,613
+20,379
+52% +$3.58M 2.55% 7
2025
Q3
$6.94M Buy
+39,234
New +$6.83M 1.74% 12
2025
Q2
Sell
-2,230
Closed -$312K 160
2025
Q1
$312K Sell
2,230
-9,858
-82% -$1.47M 0.1% 115
2024
Q4
$1.74M Buy
+12,088
New +$1.72M 0.51% 45

Other funds holding IAI

Prostatis Group's IAI Position: Q2 2026 in Review

Prostatis Group increased its iShares US Broker-Dealers & Securities Exchanges ETF (IAI) stake by 33% in Q2 2026, buying an estimated $1.91M and bringing the position to 43,658 shares worth $7.65M. The position accounts for 1.78% of the portfolio, ranked #12.

Prostatis Group first reported a position in IAI in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.7M in Q4 2025. 191 funds tracked by Wall St. Rank hold IAI as of Q2 2026.

  • Prostatis Group held 43,658 shares of iShares US Broker-Dealers & Securities Exchanges ETF worth $7.65M as of Q2 2026.
  • Prostatis Group bought 10,732 iShares US Broker-Dealers & Securities Exchanges ETF shares in Q2 2026, an estimated $1.91M.
  • iShares US Broker-Dealers & Securities Exchanges ETF made up 1.78% of Prostatis Group's portfolio in Q2 2026, its #12 holding.
  • Prostatis Group first reported a position in iShares US Broker-Dealers & Securities Exchanges ETF in Q4 2024 and has held it in 6 quarters since.
  • Prostatis Group's iShares US Broker-Dealers & Securities Exchanges ETF position peaked at $10.7M in Q4 2025.
  • 191 funds tracked by Wall St. Rank held iShares US Broker-Dealers & Securities Exchanges ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.